rs371511979

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM1BP4_Strong

The NM_024589.3(ROGDI):​c.781T>C​(p.Phe261Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000334 in 1,557,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. F261F) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

ROGDI
NM_024589.3 missense

Scores

2
2
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 6.31

Publications

0 publications found
Variant links:
Genes affected
ROGDI (HGNC:29478): (rogdi atypical leucine zipper) Involved in brain development; neurogenesis; and odontogenesis of dentin-containing tooth. Located in nuclear envelope. Implicated in Kohlschutter-Tonz syndrome. [provided by Alliance of Genome Resources, Apr 2022]
ROGDI Gene-Disease associations (from GenCC):
  • amelocerebrohypohidrotic syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM1
In a mutagenesis_site Decreased protein stability. (size 0) in uniprot entity ROGDI_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.059770256).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024589.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ROGDI
NM_024589.3
MANE Select
c.781T>Cp.Phe261Leu
missense
Exon 10 of 11NP_078865.1
ROGDI
NR_046480.2
n.788T>C
non_coding_transcript_exon
Exon 9 of 10

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ROGDI
ENST00000322048.12
TSL:1 MANE Select
c.781T>Cp.Phe261Leu
missense
Exon 10 of 11ENSP00000322832.6
ROGDI
ENST00000591392.5
TSL:3
c.709T>Cp.Phe237Leu
missense
Exon 9 of 9ENSP00000467509.1
ROGDI
ENST00000586504.5
TSL:5
c.509T>Cp.Leu170Pro
missense
Exon 6 of 7ENSP00000465076.1

Frequencies

GnomAD3 genomes
AF:
0.000142
AC:
17
AN:
120100
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000448
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000178
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000620
GnomAD2 exomes
AF:
0.0000517
AC:
13
AN:
251256
AF XY:
0.0000515
show subpopulations
Gnomad AFR exome
AF:
0.000493
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000244
AC:
35
AN:
1437136
Hom.:
0
Cov.:
37
AF XY:
0.0000308
AC XY:
22
AN XY:
714796
show subpopulations
African (AFR)
AF:
0.000337
AC:
11
AN:
32612
American (AMR)
AF:
0.000139
AC:
6
AN:
43270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25304
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38552
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85284
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51714
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5644
European-Non Finnish (NFE)
AF:
0.0000119
AC:
13
AN:
1096082
Other (OTH)
AF:
0.0000852
AC:
5
AN:
58674
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000141
AC:
17
AN:
120186
Hom.:
0
Cov.:
32
AF XY:
0.000119
AC XY:
7
AN XY:
58638
show subpopulations
African (AFR)
AF:
0.000446
AC:
14
AN:
31364
American (AMR)
AF:
0.000178
AC:
2
AN:
11234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2858
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4444
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3732
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8410
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
232
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
55490
Other (OTH)
AF:
0.000613
AC:
1
AN:
1630
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000102
Hom.:
0
Bravo
AF:
0.000136
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000412
AC:
5
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Aug 05, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.781T>C (p.F261L) alteration is located in exon 10 (coding exon 10) of the ROGDI gene. This alteration results from a T to C substitution at nucleotide position 781, causing the phenylalanine (F) at amino acid position 261 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Amelocerebrohypohidrotic syndrome Uncertain:1
Aug 27, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces phenylalanine with leucine at codon 261 of the ROGDI protein (p.Phe261Leu). The phenylalanine residue is moderately conserved and there is a small physicochemical difference between phenylalanine and leucine. This variant is present in population databases (rs371511979, ExAC 0.04%). This variant has not been reported in the literature in individuals affected with ROGDI-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.77
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
22
DANN
Benign
0.90
DEOGEN2
Benign
0.049
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.034
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.94
D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.060
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L
PhyloP100
6.3
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.15
Sift
Benign
0.86
T
Sift4G
Benign
1.0
T
Polyphen
0.0040
B
Vest4
0.47
MutPred
0.73
Loss of catalytic residue at F261 (P = 0.004)
MVP
0.12
MPC
0.023
ClinPred
0.10
T
GERP RS
5.1
Varity_R
0.49
gMVP
0.67
Mutation Taster
=47/53
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371511979; hg19: chr16-4847756; API